ALC Alcon Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 46
Relative Strength: Rel. Strength: 32
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 46

EPS in 2026 (TTM): $1.31

Last Report Period Date: Jun 30, 2026

Currently, ALC's 12-month EPS stands at $1.31, according to the most recent financial reports. During 2025, ALC reported a per-share earnings of $1.99, which shows a decline compared to the EPS of $2.06 recorded in 2024. ALC recorded an EPS of $0 for the quarterly period ending on Jun 30, 2026.

ALC earnings history

Historical annual and quarterly earnings per share (EPS) data for Alcon
EPS (TTM)
$1.31
EPS Growth YoY (Quarterly)
-100%
EPS (Quarterly)
$0
EPS Growth (Quarterly)
-100%

In 2025, Alcon's earnings per share was $1.99, a decline of 3.4% from $2.06 in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $0, reflecting a 100% decline compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $1.31. During 2024, the annual earnings per share was $2.06, representing an increase of 4% compared to 2023.

ALC EPS vs price chart

ALC EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-100%
EPS growth YoY
-3.4%
EPS growth 3Y avg
43%
EPS growth 5Y avg
N/A

In the past 12 months, Alcon has recorded an earnings per share growth rate of -100% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 43% per year.

ALC Earnings Waterfall

Breakdown of revenue, profit and net income for Alcon

ALC Earnings vs Peers

What are the earnings of ALC compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
BSX Boston Scientific Corp 17.39 55.6% 63.3% N/A
COO Cooper Companies Inc 18.57 -4.6% -1.2% 9.2%
ZBH Zimmer Biomet Holdings Inc 22.3 -20% 47.9% N/A
MDT Medtronic Plc 22.74 3.3% 9.8% 6.9%
SYK Stryker Corp 29.01 8% 10.9% 14.8%
ABT Abbott Laboratories 33.1 -51.4% -1.8% 8.2%
ISRG Intuitive Surgical Inc 47.8 22.3% 29.1% 21.5%
ALC Alcon Inc 48.09 -3.4% 43% N/A
EW Edwards Lifesciences Corp 49.01 -73.6% -9.2% 6.9%
BDX Becton Dickinson & Company 56.44 -0.9% -0.6% 16.2%
TFX Teleflex Incorporated N/A -1,462.4% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.